Management of postoperative Crohn’s disease

References

• Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 2013. [Epub ahead of print]
   Google Scholar
• Chatu S, Subramanian V, Saxena S, Pollok RC. The role of thiopurines in reducing the need for surgical resection in Crohn’s disease: a systematic review and meta-analysis. Am J Gastroenterol 2014;109(1):23-34. quiz 35
   PubMed Web of Science ®Google Scholar
• Costa J, Magro F, Caldeira D, et al. Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2013;19(10):2098-110
   PubMed Web of Science ®Google Scholar
• van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB. Prevention of postoperative recurrence of Crohn’s disease. J Crohns Colitis 2012;6(6):637-46
   PubMedGoogle Scholar
• Buisson A, Chevaux JB, Allen PB, et al. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther 2012;35(6):625-33
   PubMed Web of Science ®Google Scholar
• Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr Gastroenterol Rep 2011;13(1):95-100
   PubMedGoogle Scholar
• Doherty G, Bennett G, Patil S, et al. Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev 2009(4):CD006873
   PubMed Web of Science ®Google Scholar
• Moss AC. Prevention of postoperative recurrence of Crohn’s disease: what does the evidence support? Inflamm Bowel Dis 2013;19(4):856-9
   PubMed Web of Science ®Google Scholar
• El-Hachem S, Regueiro M. Postoperative Crohn’s disease: prevention and treatment. Expert Rev Gastroenterol Hepatol 2009;3(3):249-56
   PubMedGoogle Scholar
• Sorrentino D. State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 2013;10(7):413-22
   PubMed Web of Science ®Google Scholar
• Hashash JG, Regueiro MD. The evolving management of postoperative Crohn’s disease. Expert Rev Gastroenterol Hepatol 2012;6(5):637-48
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Watanabe T. Strategies for the prevention of postoperative recurrence of Crohn’s disease. Colorectal Dis 2013;15(12):1471-80
   PubMed Web of Science ®Google Scholar
• Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn’s disease: what does the future hold? Drugs 2013;73(16):1749-59
   PubMed Web of Science ®Google Scholar
• Nos P, Domenech E. Postoperative Crohn’s disease recurrence: a practical approach. World J Gastroenterol 2008;14(36):5540-8
   PubMedGoogle Scholar
• Borowiec AM, Fedorak RN. Predicting, treating and preventing postoperative recurrence of Crohn’s disease: the state of the field. Can J Gastroenterol 2011;25(3):140-6
   PubMedGoogle Scholar
• Swoger JM, Regueiro M. Preventive therapy in postoperative Crohn’s disease. Curr Opin Gastroenterol 2010;26(4):337-43
   PubMedGoogle Scholar
• Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis 2010;4(1):63-101
   PubMed Web of Science ®Google Scholar
• Spinelli A, Sacchi M, Fiorino G, et al. Risk of postoperative recurrence and postoperative management of Crohn’s disease. World J Gastroenterol 2011;17(27):3213-19
   PubMed Web of Science ®Google Scholar
• Buisson A, Chevaux JB, Bommelaer G, Peyrin-Biroulet L. Diagnosis, prevention and treatment of postoperative Crohn’s disease recurrence. Dig Liver Dis 2012;44(6):453-60
   PubMedGoogle Scholar
• Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990;99(4):956-63
   PubMed Web of Science ®Google Scholar
• Biancone L, Onali S, Calabrese E, et al. Non-invasive techniques for assessing postoperative recurrence in Crohn’s disease. Dig Liver Dis 2008;40(Suppl 2):S265-70
   Google Scholar
• Bourreille A, Jarry M, D’Halluin PN, et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut 2006;55(7):978-83
   PubMed Web of Science ®Google Scholar
• Pons Beltran V, Nos P, Bastida G, et al. Evaluation of postsurgical recurrence in Crohn’s disease: a new indication for capsule endoscopy? Gastrointest Endosc 2007;66(3):533-40
   PubMed Web of Science ®Google Scholar
• Biancone L, Calabrese E, Petruzziello C, et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn’s disease. Inflamm Bowel Dis 2007;13(10):1256-65
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008;27(2):146-54
   PubMed Web of Science ®Google Scholar
• Castiglione F, Bucci L, Pesce G, et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn’s disease. Inflamm Bowel Dis 2008;14(9):1240-5
   PubMed Web of Science ®Google Scholar
• Calabrese E, Petruzziello C, Onali S, et al. Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009;15(11):1635-42
   PubMed Web of Science ®Google Scholar
• Paredes JM, Ripolles T, Cortes X, et al. Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn’s disease. J Crohns Colitis 2013;7(3):192-201
   PubMedGoogle Scholar
• Soyer P, Boudiaf M, Sirol M, et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology 2010;254(3):755-64
   PubMed Web of Science ®Google Scholar
• Mao R, Gao X, Zhu ZH, et al. CT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopy. Inflamm Bowel Dis 2013;19(5):977-82
   PubMed Web of Science ®Google Scholar
• Sailer J, Peloschek P, Reinisch W, et al. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 2008;18(11):2512-21
   PubMed Web of Science ®Google Scholar
• Koilakou S, Sailer J, Peloschek P, et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolic resection. Inflamm Bowel Dis 2010;16(2):198-203
   PubMed Web of Science ®Google Scholar
• Regueiro M, Kip KE, Schraut W, et al. Crohn’s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis 2011;17(1):118-26
   PubMed Web of Science ®Google Scholar
• Walters TD, Steinhart AH, Bernstein CN, et al. Validating Crohn’s disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis 2011;17(7):1547-56
   PubMed Web of Science ®Google Scholar
• Orlando A, Modesto I, Castiglione F, et al. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn’s disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci 2006;10(1):17-22
   PubMedGoogle Scholar
• Lamb CA, Mohiuddin MK, Gicquel J, et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn’s disease. Br J Surg 2009;96(6):663-74
   PubMed Web of Science ®Google Scholar
• Scarpa M, D’Inca R, Basso D, et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn’s disease. Dis Colon Rectum 2007;50(6):861-9
   PubMed Web of Science ®Google Scholar
• Lasson A, Strid H, Ohman L, et al. Fecal calprotectin one year after ileocaecal resection for Crohn’s disease - a comparison with findings at ileocolonoscopy. J Crohns Colitis 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease. Dig Dis Sci 2008;53(9):2524-31
   PubMed Web of Science ®Google Scholar
• Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol Ther 2010;31(8):802-9
   PubMed Web of Science ®Google Scholar
• Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn’s disease. The IOIBD Budesonide Study Group. Gastroenterology 1999;116(2):294-300
   PubMed Web of Science ®Google Scholar
• Ewe K, Bottger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn’s disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999;11(3):277-82
   PubMed Web of Science ®Google Scholar
• Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn’s disease. Gut 2001;49(1):42-6
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 1995;108(6):1617-21
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005;128(4):856-61
   PubMed Web of Science ®Google Scholar
• Ford AC, Khan KJ, Talley NJ, Moayyedi P. 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol 2011;106(3):413-20
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol 2009;104(8):2089-96
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Avellini C, et al. Prevention of postoperative recurrence of Crohn’s disease by infliximab. Eur J Gastroenterol Hepatol 2006;18(4):457-9
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med 2007;167(16):1804-7
   PubMedGoogle Scholar
• Sorrentino D, Paviotti A, Terrosu G, et al. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol 2010;8(7):591-9. e591; quiz e578-99
   PubMed Web of Science ®Google Scholar
• Sakuraba A, Sato T, Matsukawa H, et al. The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn’s disease patients: a pilot open-labeled prospective study. Int J Colorectal Dis 2012;27(7):947-52
   PubMed Web of Science ®Google Scholar
• Araki T, Uchida K, Okita Y, et al. The impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case-control study. Surg Today 2014;44(2):291-6
   PubMedGoogle Scholar
• Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 2009;136(2):441-50. e441; quiz 716
   PubMed Web of Science ®Google Scholar
• Regueiro M, El-Hachem S, Kip KE, et al. Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease. Dig Dis Sci 2011;56(12):3610-15
   PubMed Web of Science ®Google Scholar
• Regueiro M, Kip KE, Baidoo L, et al. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol 2014. [Epub ahead of print]
   Google Scholar
• Yoshida K, Fukunaga K, Ikeuchi H, et al. Scheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm Bowel Dis 2012;18(9):1617-23
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Felice C, Papa A, et al. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. J Crohns Colitis 2013;7(12):e623-9
   PubMedGoogle Scholar
• Savarino E, Dulbecco P, Bodini G, et al. Prevention of postoperative recurrence of Crohn’s disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol 2012;24(4):468-70
   PubMedGoogle Scholar
• Aguas M, Bastida G, Cerrillo E, et al. Adalimumab in prevention of postoperative recurrence of Crohn’s disease in high-risk patients. World J Gastroenterol 2012;18(32):4391-8
   PubMed Web of Science ®Google Scholar
• Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn’s disease: a prospective, two-year, single center, pilot study. J Crohns Colitis 2012;6(9):924-31
   PubMed Web of Science ®Google Scholar
• De Cruz P KM, Hamilton AL, et al. Adalimumab prevents post-operative Crohn’s disease recurrence, and is superior to thiopurines: early results from the POCER Study. Gastroenterology 2012;142(5):S212
   PubMedGoogle Scholar
• Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol 2013;108(11):1731-42
   PubMed Web of Science ®Google Scholar
• Shen FC, Zhang HJ, Zhao XD, et al. Purine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Int J Clin Pract 2012;66(8):758-66
   PubMed Web of Science ®Google Scholar
• Regueiro M. Management and prevention of postoperative Crohn’s disease. Inflamm Bowel Dis 2009;15(10):1583-90
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Clinical perspectives in Crohn’s disease. Turning traditional treatment strategies on their heads: current evidence for “step-up” versus “top-down”. Rev Gastroenterol Disord 2007;7(Suppl 2):S17-22
   Google Scholar
• Sakatani A, Fujiya M, Ito T, et al. Infliximab extends the duration until the first surgery in patients with Crohn’s disease. Biomed Res Int 2013;2013:879491
   PubMedGoogle Scholar
• Yang Z, Ye X, Wu Q, et al. A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn’s disease. Int J Surg 2014. [Epub ahead of print]
   Google Scholar
• Doherty GA, Miksad RA, Cheifetz AS, Moss AC. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn’s disease. Inflamm Bowel Dis 2012;18(9):1608-16
   PubMedGoogle Scholar
• Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn’s disease: results of a decision analysis. Am J Gastroenterol 2011;106(11):2009-17
   PubMed Web of Science ®Google Scholar
• Biancone L, Cretella M, Tosti C, et al. Local injection of infliximab in the postoperative recurrence of Crohn’s disease. Gastrointest Endosc 2006;63(3):486-92
   PubMedGoogle Scholar
• Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot study. Inflamm Bowel Dis 2009;15(10):1460-6
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Paviotti A, et al. Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab--a pilot study. Dig Dis Sci 2012;57(5):1341-8
   PubMed Web of Science ®Google Scholar
• Bordeianou L, Stein SL, Ho VP, et al. Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn’s disease? Surgery 2011;149(1):72-8
   PubMed Web of Science ®Google Scholar